Genprex, Inc.Genprex, Inc.Genprex, Inc.

Genprex, Inc.

No trades
See on Supercharts
Market capitalization
‪4.49 M‬USD
−22.93USD
‪−30.86 M‬USD
‪1.85 M‬
Beta (1Y)
4.05

About Genprex, Inc.

CEO
J. Rodney Varner
Headquarters
Austin
Employees (FY)
26
Founded
2009
ISIN
US3724462037
FIGI
BBG00F7T0157
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GNPX is 2.30 USD — it has decreased by 2.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Genprex, Inc. stocks are traded under the ticker GNPX.
Genprex, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Genprex, Inc. has a max estimate of 10.00 USD and a min estimate of 8.00 USD.
GNPX earnings for the last quarter are −4.60 USD whereas the estimation was −4.00 USD which accounts for −15.00% surprise. Estimated earnings for the next quarter are −5.50 USD. See more details about Genprex, Inc. earnings.
Yes, you can track Genprex, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, GNPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Genprex, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GNPX reached its all-time high on Apr 30, 2018 with the price of 778.00 USD, and its all-time low was 2.50 USD and was reached on Mar 27, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 26.00 employees. See our rating of the largest employees — is Genprex, Inc. on this list?